EXYMES LIMITED
Company number 15067075 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
EXYMES LIMITED - Analysis Report
Company Number: 15067075
Analysis Date: 2025-07-29 19:38 UTC
Financial Health Assessment: EXYMES LIMITED (As of 31 August 2024)
1. Financial Health Score: Grade D
Explanation:
EXYMES LIMITED exhibits significant financial distress indicators, primarily negative net assets and severely negative working capital. The company is in its infancy (incorporated in 2023) with limited operating history, but the current financials indicate symptoms of financial strain requiring urgent attention.
2. Key Vital Signs
| Metric | Value | Interpretation |
|---|---|---|
| Fixed Assets | £130,160 | Investment in long-term assets, mainly intangible assets (£111k) and plant & machinery. Shows capital deployment but no immediate liquidity. |
| Current Assets | £1 | Extremely low current assets; virtually no liquid resources. |
| Current Liabilities | £159,569 | High short-term obligations; pressure on liquidity is severe. |
| Net Current Assets | £-159,568 | Negative working capital, indicating inability to meet short-term debts with current assets ("symptom of liquidity distress"). |
| Total Assets Less Current Liabilities | £-29,408 | Negative, indicating total assets cannot cover current liabilities. |
| Net Assets / Shareholders’ Funds | £-29,408 | Negative equity, a critical warning sign of insolvency risk or undercapitalization. |
| Called-up Share Capital | £1 | Minimal paid-in capital; insufficient buffer against losses. |
3. Diagnosis
Symptoms Analysis:
- Liquidity Crisis: The company’s current assets are almost negligible (£1), while current liabilities stand at £159,569, creating a severe liquidity shortfall. This “heart arrhythmia” of the balance sheet means EXYMES LIMITED does not have sufficient short-term resources to pay immediate debts.
- Negative Net Worth: Shareholders’ funds are negative (£-29,408), a “symptom” analogous to a patient with a weakened immune system — the company’s financial foundation is compromised.
- Young Company, High Initial Investment: The large intangible assets balance (£111k) suggests capital invested in intellectual property or software development, which is amortized over 10 years. Tangible assets (plant and machinery) are £18,904, indicating physical investment. However, these assets are illiquid and cannot quickly be converted to cash.
- No Audit Required: As a small company, accounts are unaudited, which might obscure underlying operational details.
- Control and Governance: The majority control lies with two individuals owning 75-100% shares each, indicating concentrated ownership but no evidence of external financial support or equity injection to cover losses so far.
Overall Diagnosis:
EXYMES LIMITED is in a fragile financial state, exhibiting symptoms akin to “financial shock.” The negative working capital and net assets suggest that without immediate intervention, the company risks insolvency or inability to continue as a going concern.
4. Prognosis
If current trends persist, the company faces a challenging road ahead. Without additional capital injection, improved cash flow management, or debt restructuring, EXYMES LIMITED may find it difficult to cover short-term obligations. However, as a newly formed entity, early-stage investment and operating losses can be common and may improve if the business model proves viable.
5. Recommendations
- Capital Injection: Immediate infusion of equity or long-term financing to shore up working capital and reduce liquidity risks. This will stabilize the “heartbeat” of the company and restore solvency.
- Cash Flow Management: Develop detailed cash flow forecasts and implement strict controls on payables and receivables to improve liquidity. Consider negotiating better payment terms with creditors.
- Asset Utilization: Review the intangible and tangible assets to ensure they contribute to revenue generation or can be leveraged/sold if necessary.
- Financial Monitoring: Establish regular financial health check-ups with focus on liquidity ratios, gearing, and profitability metrics.
- Strategic Review: Evaluate the business plan and operational model to identify cost-saving opportunities or revenue enhancement strategies.
- Consider Professional Advice: Engage with insolvency practitioners or financial advisors if liquidity pressures worsen to explore restructuring options.
Executive Summary
EXYMES LIMITED is currently exhibiting severe financial distress characterized by negative net assets and a critical liquidity shortfall, placing it at risk of insolvency if no corrective actions are taken. As a young company with significant intangible investments, it requires urgent capital support and improved cash flow management to stabilize its financial health and ensure sustainable operations. Early intervention is essential to prevent further deterioration and to support future growth potential.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.